Shelterin dysfunction and p16INK4a-Mediated Growth inhibition in HIV-1-specific CD8 T cells

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5533-5540

  Lichterfeld, Mathias ^a   Cung, Thai ^b   Seiss, Katherine ^b   Rosenberg, Eric S ^a   Pereyr, Florencia ^b,c   Yu, Xu G ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; NUCLEOPROTEIN; SHELTERIN; UNCLASSIFIED DRUG; SHELTERIN, HUMAN; TELOMERE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; DOWN REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SPECIES DIFFERENCE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; SPECIES SPECIFICITY; TELOMERE-BINDING PROTEINS; UP-REGULATION;

EID: 84861312862     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00196-12     Document Type: Article

References (42)

1. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. 2007. Accelerated immune senescence and HIV-1 infection. Exp. Gerontol. 42:432-437.
2. Appay V, Sauce D. 2008. Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214:231-241.
3. Beausejour CM, Campisi J. 2006. Ageing: balancing regeneration and cancer. Nature 443:404-405.
4. Betts MR, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789.
5. Brenchley JM, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
6. Cao W, et al. 2009. Premature aging of T cells is associated with faster HIV-1 disease progression. J. Acquir. Immune Defic. Syndr. 50:137-147.
7. Celli GB, de Lange T. 2005. DNA processing is not required for ATMmediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7:712-718.
8. Cesare AJ, Reddel RR. 2008. Telomere uncapping and alternative lengthening of telomeres. Mech. Ageing Dev. 129:99-108.
9. Chebel A, et al. 2009. Telomere uncapping during in vitro T-lymphocyte senescence. Aging Cell 8:52-64.
10. Day CL, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354.
11. de Lange T. 2005. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100-2110.
12. Dimitrova N, de Lange T. 2006. MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres. Genes Dev. 20:3238-3243.
13. Effros RB, et al. 1996. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10:F17-F22.
14. Effros RB, Dagarag M, Spaulding C, Man J. 2005. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev. 205:147-157.
15. Ferreira C, Barthlott T, Garcia S, Zamoyska R, Stockinger B. 2000. Differential survival of naive CD4 and CD8 T cells. J. Immunol. 165:3689-3694.
16. Foulds KE, et al. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:1528-1532.
17. Homann D, Teyton L, Oldstone MB. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7:913-919.
18. Janzen V, et al. 2006. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443:421-426.
19. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. 1999. p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321-1325.
20. Krishnamurthy J, et al. 2006. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443:453-457.
21. Laharanne E, et al. 2010. CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. Mod Pathol. 23:547-558.
22. Lichterfeld M, et al. 2004. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J. Exp. Med. 200:701-712.
23. Lichterfeld M, et al. 2008. Telomerase activity of HIV-1-specific CD8+T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood 112:3679-3687.
24. Liu Y, et al. 2011. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood 117:3257-3267.
25. Liu Y, et al. 2009. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell 8:439-448.
26. Liu Y, Sharpless NE. 2009. Tumor suppressor mechanisms in immune aging. Curr. Opin. Immunol. 21:431-439.
27. Migliaccio M, Raj K, Menzel O, Rufer N. 2005. Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytes. J. Immunol. 174:3335-3343.
28. Migueles SA, et al. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
29. Onen NF, Overton ET. 2011. A review of premature frailty in HIVinfected persons; another manifestation of HIV-related accelerated aging. Curr. Aging Sci. 4:33-41.
30. Palm W, de Lange T. 2008. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42:301-334.
31. Poncet D, et al. 2008. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood 111:2388-2391.
32. Rai R, Chang S. 2011. Probing the telomere damage response. Methods Mol. Biol. 735:145-150.
33. Rayess H, Wang MB, Srivatsan ES. 2012. Cellular senescence and tumor suppressor gene p16. Int. J. Cancer 130:1715-1725.
34. Shankar P, et al. 2000. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood 96:3094-3101.
35. Stockmann M, et al. 2000. Mechanisms of epithelial barrier impairment in HIV infection. Ann. N. Y. Acad. Sci. 915:293-303.
36. Takai H, Smogorzewska A, de Lange T. 2003. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:1549-1556.
37. Trautmann L, et al. 2006. Upregulation of PD-1 expression on HIVspecific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12:1198-1202.
38. van Baarle D, Tsegaye A, Miedema F, Akbar A. 2005. Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol. Lett. 97:19-29.
39. van Steensel B, de Lange T. 1997. Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743.
40. van Steensel B, Smogorzewska A, de Lange T. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413.
41. Velu V, et al. 2009. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458:206-210.
42. Wolthers KC, et al. 1996. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 274:1543-1547.